| Abstract: | Investigated the effects of centrally administered spiroperidol, a dopamine receptor blocking agent, on self-stimulation of the nucleus accumbens and medial prefrontal cortex in the rat. Spiroperidol in a volume of 1 μl was microinjected into the region of the stimulating electrodes. Self-stimulation of the nucleus accumbens was significantly attenuated by .75, 1.0, and 2.0 μg spiroperidol. Control microinjections of the drug vehicle had no effect. Spiroperidol microinjected into the nucleus accumbens contralateral to the stimulating electrode, as a control for possible motor or nonspecific effects, did not attenuate self-stimulation. Microinjections of spiroperidol into the region of the stimulating electrodes in the prefrontal cortex had no consistent effect on self-stimulation with the two lower doses, but did result in attenuation at the 2.0 μg dose. Self-stimulation of the nucleus accumbens was not changed by microinjections of spiroperidol into the ipsilateral or contralateral prefrontal cortex. Similarly, self-stimulation of the prefrontal cortex was not altered by microinjections of spiroperidol into the nucleus accumbens. By controlling for nonspecific effects of spiroperidol, the results provide further evidence that dopaminergic neurons contribute to self-stimulation of the nucleus accumbens. (French summary) (38 ref) (PsycINFO Database Record (c) 2010 APA, all rights reserved) |
